Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

WVE

Wave Life Sciences Ltd

Dec 12 • 02:52PM ET

14.04

Dollar change -1.37
Percentage change -8.89	%

Healthcare • Biotechnology • Singapore • NASD

Peers: IONS ALNY SRPT ARWR MRNA NBIX VRTX BIIB QURE EDIT

| Held by: IWM VXF IBB IWO SCHA KOMP VTWO VHT LFSC IWC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.11	Insider Own	22.54%	Shs Outstand	148.39M	Perf Week	-2.77%
Market Cap	2.14B	Forward P/E	-	EPS next Y	-1.06	Insider Trans	7.14%	Shs Float	118.14M	Perf Month	-11.64%
Income	-142.52M	PEG	-	EPS next Q	-0.19	Inst Own	73.94%	Short Float	5.86%	Perf Quarter	139.59%
Sales	53.61M	P/S	39.94	EPS this Y	-113.04%	Inst Trans	44.87%	Short Ratio	3.65	Perf Half Y	116.67%
Book/sh	0.95	P/B	14.71	EPS next Y	8.22%	ROA	-51.04%	Short Interest	6.93M	Perf Year	214.80%
Cash/sh	2.04	P/C	6.89	EPS next 5Y	-	ROE	-243.82%	52W Range	3.50 - 16.74	Perf YTD	178.02%
Dividend Est.	-	P/FCF	-	EPS past 5Y	36.03%	ROI	-84.19%	52W High	-16.10%	Beta	-1.13
Dividend TTM	-	Quick Ratio	1.90	Sales past 5Y	610.91%	Gross Margin	83.79%	52W Low	301.14%	ATR (14)	0.96
Dividend Ex-Date	-	Current Ratio	1.90	EPS Y/Y TTM	-28.22%	Oper. Margin	-283.63%	RSI (14)	47.29	Volatility	5.11% 6.70%
Employees	268	Debt/Eq	0.18	Sales Y/Y TTM	-37.29%	Profit Margin	-265.84%	Recom	1.20	Target Price	22.60
Option/Short	Yes / Yes	LT Debt/Eq	0.13	EPS Q/Q	-812.54%	Payout	-	Rel Volume	0.71	Prev Close	15.41
Sales Surprise	-146.22%	EPS Surprise	-66.20%	Sales Q/Q	-115.60%	Earnings	Nov 12 BMO	Avg Volume	1.90M	Price	14.04
SMA20	-3.68%	SMA50	3.46%	SMA200	79.57%	Trades		Volume	1,125,456	Change	-8.89%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-16-24	Upgrade	Raymond James	Outperform → Strong Buy	$22
Sep-27-24	Resumed	JP Morgan	Overweight	$10 → $13
Sep-19-24	Initiated	B. Riley Securities	Buy	$11
Sep-09-24	Initiated	JP Morgan	Overweight	$10
May-15-24	Initiated	Wells Fargo	Overweight	$11
Dec-19-23	Upgrade	Leerink Partners	Market Perform → Outperform	$5 → $12
Jul-05-23	Initiated	Raymond James	Outperform	$7
May-24-23	Downgrade	Jefferies	Buy → Hold	$7 → $5
Dec-15-20	Resumed	H.C. Wainwright	Buy	$20
Oct-23-20	Initiated	RBC Capital Mkts	Sector Perform	$13
Dec-31-19	Downgrade	SVB Leerink	Outperform → Mkt Perform	$33 → $10
Nov-01-19	Initiated	Guggenheim	Buy	$43
Jul-15-19	Initiated	Cowen	Market Perform
Apr-17-19	Reiterated	H.C. Wainwright	Buy	$49 → $33
Aug-07-18	Initiated	Stifel	Buy	$56
Jul-23-18	Initiated	H.C. Wainwright	Buy	$49
Mar-19-18	Reiterated	Mizuho	Buy	$34 → $65
Feb-15-17	Initiated	H.C. Wainwright	Buy	$41
Nov-10-16	Resumed	Leerink Partners	Outperform
Dec-07-15	Initiated	Sun Trust Rbsn Humphrey	Buy	$26

Show Previous Ratings

Nov-26-24 08:30AM	Wave Life Sciences to Present at Upcoming Investor Conferences (GlobeNewswire)
Nov-15-24 08:30AM	Wave Life Sciences to Present at Jefferies London Healthcare Conference (GlobeNewswire) -8.87%
Nov-13-24 02:08AM	WAVE Life Sciences Ltd (WVE) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... (GuruFocus.com)
Nov-12-24 09:00AM	Wave Life Sciences (WVE) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
07:58AM	Wave Life Sciences: Q3 Earnings Snapshot (Associated Press Finance)
07:30AM	Loading…
07:30AM	Wave Life Sciences Reports Third Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
Nov-11-24 07:08AM	WAVE Life Sciences Ltd (WVE) Q3 2024: Everything You Need to Know Ahead of Earnings (GuruFocus.com)
Nov-05-24 10:00AM	Wave Life Sciences (WVE) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Nov-04-24 04:05PM	Wave Life Sciences Third Quarter 2024 Financial Results Scheduled for November 12, 2024 (GlobeNewswire)
Oct-30-24 04:45PM	Wave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA Editing Programs (GlobeNewswire)
Oct-29-24 05:47PM	How to play biotech stocks: Insmed and Wave Life Sciences (Yahoo Finance Video)
Oct-28-24 09:55AM	Wall Street Analysts Predict a 34.53% Upside in Wave Life Sciences (WVE): Here's What You Should Know (Zacks)
Oct-24-24 05:53AM	1 Brand-New Big Reason to Buy This Biotech Stock Right Now (Motley Fool)
Oct-23-24 12:00PM	What Makes Wave Life Sciences (WVE) a Strong Momentum Stock: Buy Now? (Zacks)
Oct-21-24 04:15PM	Korro Bio Is Lagging Wave Life Sciences In RNA Editing. Why It Could Ultimately Lead The Space. (Investor's Business Daily)
10:56AM	Loading…
Oct-17-24 10:56AM	Wave Life Sciences Shares Surge After RNA Editing Discovery (GuruFocus.com)
07:33AM	Wave Life Sciences (WVE) Moves 74.1% Higher: Will This Strength Last? (Zacks)
Oct-16-24 04:20PM	Wave Life Sciences Just Edited RNA. Why Its Key Rival, Korro Bio, Skyrocketed. (Investor's Business Daily) +74.07%
04:13PM	RNA-Editing Stocks Soar by Record on Wave Lifes Trial Data (Bloomberg)
01:16PM	Wave Life Sciences Stock Climbs on RNA Editing Progress (The Wall Street Journal)
08:44AM	Wave Life Sciences (WVE): Advancing Gene Therapy for Duchenne Muscular Dystrophy (Insider Monkey)
08:30AM	Wave Life Sciences Announces First-Ever Therapeutic RNA Editing in Humans Achieved in RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency (GlobeNewswire)
08:25AM	Wave Life Sciences Announces Upcoming Virtual Research Day on Wednesday, October 30, 2024 (GlobeNewswire)
08:15AM	Wave sees RNA editing validation in early trial results (BioPharma Dive)
Oct-11-24 11:56AM	GSK Bought More Shares of Biotech Wave Life Sciences (Barrons.com)
09:55AM	How Much Upside is Left in Wave Life Sciences (WVE)? Wall Street Analysts Think 89.71% (Zacks)
Oct-09-24 05:36PM	WAVE Life Sciences Ltd (WVE) Q2 2024 Earnings Call Highlights: Strategic Advances Amid Rising ... (GuruFocus.com) +5.12%
Oct-03-24 08:15AM	Better Biotech Stock: Wave Life Sciences vs. Sarepta Therapeutics (Motley Fool)
Oct-01-24 09:20AM	Wave Life Sciences Announces Closing of Upsized Public Offering of Ordinary Shares and Pre-Funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares (GlobeNewswire)
Sep-30-24 08:30AM	Wave Life Sciences to Present at Chardan 8th Annual Genetic Medicines Conference (GlobeNewswire)
09:14PM	Loading…
Sep-25-24 09:14PM	Wave Life Sciences Prices Upsized $200 Million Public Offering of Ordinary Shares and Pre-Funded Warrants (GlobeNewswire) +10.01% -10.99%
06:32AM	Waves stock swells as it eyes approval following Phase II DMD victory (Clinical Trials Arena)
Sep-24-24 04:01PM	Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants (GlobeNewswire) +53.37%
11:19AM	Wave Life Sciences Stock Surges On Promising Interim Data From Mid-Stage Study Of Muscular Disorder Drug (Benzinga)
07:30AM	Wave Life Sciences Announces Positive Interim Data from FORWARD-53 Clinical Trial Evaluating WVE-N531 in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping (GlobeNewswire)
Aug-24-24 01:17AM	Insider Selling: President and CEO Paul Bolno Sells 48,366 Shares of WAVE Life Sciences Ltd (WVE) (GuruFocus.com)
Aug-12-24 08:30AM	Wave Life Sciences Receives FDA Rare Pediatric Disease Designation for WVE-N531 for the Treatment of Duchenne Muscular Dystrophy (GlobeNewswire)
Aug-08-24 08:45AM	Wave Life Sciences (WVE) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
07:47AM	Wave Life Sciences: Q2 Earnings Snapshot (Associated Press Finance)
07:30AM	Wave Life Sciences Reports Second Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
Aug-01-24 08:30AM	Wave Life Sciences Second Quarter 2024 Financial Results Scheduled for August 8, 2024 (GlobeNewswire) -6.81%
Jun-25-24 07:30AM	Wave, with new data, plots path forward for Huntingtons drug (BioPharma Dive) -8.45%
07:30AM	Wave Life Sciences Announces Positive Results from Phase 1b/2a SELECT-HD Trial with First Clinical Demonstration of Allele-Selective Mutant Huntingtin Lowering in Huntington's Disease (GlobeNewswire)
Jun-12-24 08:30AM	Wave Life Sciences Announces Upcoming Presentations Highlighting Novel siRNA Program in Obesity and Leadership in RNA Editing (GlobeNewswire)
May-30-24 08:30AM	Wave Life Sciences to Present at 2024 Jefferies Global Healthcare Conference (GlobeNewswire)
May-15-24 07:16AM	Wells Fargo Starts WAVE Life Sciences With Overweight Rating, $11 Price Target (MT Newswires)
May-10-24 04:53PM	Wave Life Sciences Ltd. (NASDAQ:WVE) Q1 2024 Earnings Call Transcript (Insider Monkey)
02:39PM	WAVE Life Sciences Reports First Quarter 2024 Financial Results (GuruFocus.com)
May-09-24 07:45AM	Wave Life Sciences: Q1 Earnings Snapshot (Associated Press Finance)
07:30AM	Wave Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
07:00AM	Wave Life Sciences Announces Appointment of Dr. Erik Ingelsson as Chief Scientific Officer (GlobeNewswire)
May-07-24 08:30AM	Wave Life Sciences to Present at 2024 RBC Capital Markets Global Healthcare Conference (GlobeNewswire)
May-02-24 08:30AM	Wave Life Sciences First Quarter 2024 Financial Results Scheduled for May 9, 2024 (GlobeNewswire)
Apr-30-24 08:30AM	Wave Life Sciences Announces Approval of First Clinical Trial Application for RestorAATion-2 Trial of WVE-006 in Individuals with Alpha-1 Antitrypsin Deficiency (AATD) (GlobeNewswire)
Apr-23-24 08:30AM	Wave Life Sciences Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and RNA Editing (GlobeNewswire)
Mar-27-24 08:30AM	Wave Life Sciences to Present at Upcoming Investor Conferences (GlobeNewswire) +6.71%
Mar-15-24 08:18AM	Billionaire Paul Tudor Jones and Insiders Love These 10 Stocks (Insider Monkey)
Mar-07-24 10:47AM	Wave Life Sciences Ltd. (NASDAQ:WVE) Q4 2023 Earnings Call Transcript (Insider Monkey) +8.43%
Mar-06-24 12:51PM	WVE Stock Earnings: WAVE Life Sciences Beats EPS, Beats Revenue for Q4 2023 (InvestorPlace) +31.32%
07:51AM	Wave Life Sciences: Q4 Earnings Snapshot (Associated Press Finance)
07:30AM	Wave Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire)
Feb-28-24 08:30AM	Wave Life Sciences Fourth Quarter and Full Year 2023 Financial Results Scheduled for March 6, 2024 (GlobeNewswire)
04:16AM	Wave Life Sciences (WVE) Surges 10.9%: Is This an Indication of Further Gains? (Zacks)
Feb-27-24 08:30AM	Wave Life Sciences Announces Upcoming Presentations at MDA Conference that Highlight Best-in-Class Potential for WVE-N531 in Duchenne Muscular Dystrophy (GlobeNewswire) +10.87%
Feb-06-24 01:17PM	Hedge Fund and Insider Trading News: John Paulson, Dan Loeb, Millennium Management, Wave Life Sciences Ltd. (WVE), Super Micro Computer Inc (SMCI), and More (Insider Monkey)
Jan-31-24 01:21PM	Hedge Fund and Insider Trading News: Ken Griffin, Seth Klarman, Millennium Management, Wave Life Sciences Ltd. (WVE), Columbia Banking System Inc (COLB), and More (Insider Monkey)
Jan-08-24 08:00AM	Wave Life Sciences Highlights Recent Achievements and Upcoming 2024 Milestones (GlobeNewswire) +5.06%
Jan-03-24 08:30AM	Wave Life Sciences to Present at 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-15-23 08:30AM	Wave Life Sciences Announces Initiation of Dosing in Phase 2 FORWARD-53 Trial of WVE-N531 in Duchenne Muscular Dystrophy (GlobeNewswire)
Dec-07-23 07:00AM	Wave Life Sciences Prices $100 Million Public Offering of Ordinary Shares (GlobeNewswire) -30.42%
Dec-06-23 04:10PM	Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants (GlobeNewswire) +9.22%
04:08PM	Wave Life Sciences Announces Initiation of Dosing in RestorAATion Clinical Program Evaluating First-Ever RNA Editing Candidate, WVE-006, for Alpha-1 Antitrypsin Deficiency (GlobeNewswire)
Nov-22-23 08:30AM	Wave Life Sciences to Present at 6 Annual Evercore ISI HealthCONx Conference (GlobeNewswire)
Nov-11-23 12:09PM	Wave Life Sciences Ltd. (NASDAQ:WVE) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-09-23 08:38AM	WAVE Life Sciences Ltd (WVE) Reports Notable Shift to Profitability in Q3 2023 (GuruFocus.com) -9.55%
07:43AM	Wave Life Sciences: Q3 Earnings Snapshot (Associated Press Finance)
07:30AM	Wave Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Nov-03-23 04:05PM	Wave Life Sciences Third Quarter 2023 Financial Results Scheduled for November 9, 2023 (GlobeNewswire) +6.02%
Sep-29-23 05:47AM	Wave Life Sciences (WVE) Soars 8.7%: Is Further Upside Left in the Stock? (Zacks)
Sep-28-23 04:15PM	Wave Life Sciences Highlights Growth Strategy for Building the Leading RNA Medicines Company in Annual R&D Day (GlobeNewswire) +8.71%
Sep-25-23 08:30AM	Wave Life Sciences to Present at the Chardan 7th Annual Genetic Medicines Conference (GlobeNewswire)
Sep-06-23 08:30AM	Wave Life Sciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire)
Sep-05-23 07:30AM	Wave Life Sciences Announces Submission of First Clinical Trial Application for WVE-006, the First-ever RNA Editing Clinical Candidate, and Plans for Upcoming Virtual R&D Day (GlobeNewswire)
Aug-23-23 11:13AM	WAVE Life Sciences Ltd. Sees a 23% Stock Price Surge Over the Past Three Months (GuruFocus.com) +6.99%
Aug-17-23 08:44AM	11 Best Biotech Penny Stocks to Buy Now (Insider Monkey)
06:40AM	7 A-Rated Biotech Stocks for Your August Buy List (InvestorPlace)
Aug-10-23 12:40PM	Wave Life Sciences Ltd. (NASDAQ:WVE) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-08-23 06:02AM	Analyst Forecasts For Wave Life Sciences Ltd. (NASDAQ:WVE) Are Surging Higher (Simply Wall St.)
Aug-04-23 06:45AM	Wave Life Sciences Ltd.'s (NASDAQ:WVE) 42% Price Boost Is Out Of Tune With Revenues (Simply Wall St.)
Aug-03-23 08:55AM	Wave Life Sciences (WVE) Reports Q2 Loss, Tops Revenue Estimates (Zacks) +15.79%
07:53AM	Wave Life Sciences: Q2 Earnings Snapshot (AP Finance)
07:30AM	Wave Life Sciences Reports Second Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Jul-27-23 08:30AM	Wave Life Sciences Second Quarter 2023 Financial Results Scheduled for August 3, 2023 (GlobeNewswire)
Jul-06-23 08:40AM	Wave Life Sciences (NASDAQ:WVE) shareholders have endured a 90% loss from investing in the stock five years ago (Simply Wall St.)
Jun-26-23 08:30AM	Wave Life Sciences Joins the Russell 2000® and Russell 3000® Indexes (GlobeNewswire)
Jun-19-23 08:00AM	Top Penny Stocks for Q3 2023 (Investopedia)
May-23-23 07:30AM	Wave Life Sciences Announces Topline Results from Phase 1b/2a FOCUS-C9 Study of WVE-004 for C9orf72-associated Amyotrophic Lateral Sclerosis and Frontotemporal Dementia (GlobeNewswire)
May-16-23 08:30AM	Wave Life Sciences to Highlight Leading RNA Editing Capability and Multimodal Discovery and Development Platform at ASGCT 26th Annual Meeting (GlobeNewswire) -7.94%
May-08-23 06:03AM	The Consensus EPS Estimates For Wave Life Sciences Ltd. (NASDAQ:WVE) Just Fell Dramatically (Simply Wall St.)
May-05-23 06:19AM	Wave Life Sciences First Quarter 2023 Earnings: Misses Expectations (Simply Wall St.) +9.32%

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BOLNO PAUL	President and CEO	Nov 25 '24	Option Exercise	2.48	50,000	124,000	267,351	Nov 27 09:00 PM
BOLNO PAUL	President and CEO	Nov 25 '24	Sale	15.00	50,000	750,000	217,351	Nov 27 09:00 PM
PAUL BOLNO	Officer	Nov 25 '24	Proposed Sale	15.00	50,000	750,000		Nov 25 05:09 PM
BOLNO PAUL	President and CEO	Nov 15 '24	Sale	14.32	51,234	733,671	217,351	Nov 15 09:00 PM
PAUL BOLNO	Officer	Nov 15 '24	Proposed Sale	14.32	51,234	733,743		Nov 15 04:16 PM
Francis Chris	See Remarks	Nov 08 '24	Option Exercise	8.17	36,000	294,120	36,000	Nov 13 08:00 PM
Francis Chris	See Remarks	Nov 08 '24	Sale	16.00	36,000	576,000	0	Nov 13 08:00 PM
CHRISTOPHER FRANCIS	Officer	Nov 08 '24	Proposed Sale	16.00	36,000	576,000		Nov 08 04:14 PM
Francis Chris	See Remarks	Oct 16 '24	Option Exercise	2.88	129,122	371,410	65,625	Oct 18 08:00 PM
Francis Chris	See Remarks	Oct 16 '24	Sale	13.67	208,836	2,855,051	0	Oct 18 08:00 PM
BOLNO PAUL	President and CEO	Oct 16 '24	Sale	15.00	90,474	1,357,110	268,585	Oct 18 08:00 PM
CHRISTOPHER FRANCIS	Officer	Oct 16 '24	Proposed Sale	13.67	208,836	2,855,051		Oct 16 04:19 PM
PAUL BOLNO	Officer	Oct 16 '24	Proposed Sale	15.00	90,474	1,357,110		Oct 16 04:13 PM
Moran Kyle	Chief Financial Officer	Oct 11 '24	Option Exercise	2.48	25,000	62,000	44,777	Oct 11 08:00 PM
GSK plc	10% Owner	Sep 27 '24	Buy	8.00	2,791,930	22,335,440	16,775,691	Oct 01 05:54 PM
Moran Kyle	Chief Financial Officer	Sep 25 '24	Sale	9.00	17,146	154,314	19,777	Sep 27 08:00 PM
KYLE MORAN	Officer	Sep 25 '24	Proposed Sale	9.00	17,146	154,314		Sep 25 09:40 PM
BOLNO PAUL	President and CEO	Aug 21 '24	Sale	5.78	48,366	279,555	359,059	Aug 23 06:00 PM
PAUL BOLNO	Officer	Aug 21 '24	Proposed Sale	5.78	48,366	279,638		Aug 21 04:24 PM
Vargeese Chandra	See Remarks	Jul 22 '24	Option Exercise	2.48	68,210	169,161	185,061	Jul 24 05:54 PM
Moran Kyle	Chief Financial Officer	Apr 03 '24	Sale	6.17	15,630	96,421	33,921	Apr 05 08:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

WVE

Wave Life Sciences Ltd

Upgrade your FINVIZ experience